Lisata Therapeutics, Inc.: Form 8-K, filed Jul 24, 2026
Filed with the SEC on Jul 24, 2026 and accepted by EDGAR at Jul 24, 2026, 12:15 ET.
Items reported
- Item 1.02 Termination of a material agreement
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-26-029541. Last ingested by Listed: Nov 10, 2026, 04:21 ET. Listed shows no prices and gives no investment advice.